Navigation Links
Hot Information for Physicians Treating Vasomotor Symptoms During the Menopausal Transition
Date:3/25/2008

ons company that specializes in high- quality communication with physicians, advanced practice clinicians, and consumers. Its highly respected, peer-reviewed journals reach more than 300,000 physicians and clinicians in surgery, psychiatry, family practice, internal medicine & obstetrics/gynecology.


'/>"/>
SOURCE The Journal of Family Practice; OBG Management
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. Updated NIH Guidelines Offer Valuable Information on Asthma Diagnosis and Management
3. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
4. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
5. IFRS Information - First Half of 2007
6. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
7. Researchers improve ability to write and store information on electronic devices
8. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
9. Stevens researchers provide new information about mass spectrometry
10. VIA Pharmaceuticals Lead Compound, VIA-2291, Chosen as a Top Ten Most Licensable Cardiovascular Program for Windhover Informations Therapeutic Area Partnerships Conference
11. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... developing new therapeutics that target the underlying mechanisms of ... Administration (FDA) has granted the company orphan drug designation ... (AML). APTO-253, a first-in-class inducer of the KLF4 gene, ... Ib clinical trial in patients with AML, high-risk myelodysplastic ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:6/2/2015)... 2015   Y-Prime, Inc ., announced today ... 2015 in Philadelphia , June ... gathering, allows influential decision makers from the Biotech ... evaluate emerging technologies such as YPrime. ... design, implementation and management of Interactive Response Technology ...
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... -- Rita Colwell, former director of the National Science ... Health" at 5:30 p.m. Monday, Oct. 3, in a ... Union. , ,Colwell headed the NSF from 1998-2004. She ... a distinguished professor at the University of Maryland and ...
... acquire healthcare information technology provider IDX Systems Corp. ... Thursday. The transaction is expected to close by early ... complementary product lines," said GE Healthcare Vice President Don ... comprehensive product line across radiology systems, across electronic health ...
... -- Third Wave Technologies Inc. , a developer ... analysis applications, is being sued by Belgium-based Innogenetics N.V. ... Meanwhile, in a separate case, Third Wave has won a ... is a provider of diagnostic and therapeutic products, with a ...
Cached Biology Technology:Third Wave sued by one firm; gets injunction against another 2
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... / b3c newswire / - Critical Outcome ... today from animal experiments carried out at a prominent ... adds to the already impressive data package for COTI-2, ... with first line therapies with low toxicity in seven ...
... of cancer mortality in children. Even if a cure ... stressful treatment which can be harmful to the developing ... gentle treatment methods. The most important childhood brain tumors ... young patients each year in Germany, and pylocytic astrocytoma, ...
... This release is available in Spanish . ... understand the trophic food chains involving microbian plankton. That is, to ... that live organisms can be classified from the perspective of nutrition. ... these levels are united one to the other, forming a chain. ...
Cached Biology News:ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4University of the Basque Country research on plankton at Urdaibai 2
...
... series offers versatile liquid handling platforms and ... wide variety of life science applications.The Freedom ... sizes (75, 100, 150 and 200 cm), ... platform that will advance with their application ...
... utilizes utilizies CTI Molecular Imaging's proprietary ... resolution, sensitivty, and a large imaging ... flexibility to image multiple mice or ... is a dedicated small animal PET ...
... Diluent (MOPS Buffered) has been developed specifically ... in solution. HRP Stabilizer prevents the ... conformation of the antibody or protein antigen ... filtered at 0.2 microns., ,Contents: Aqueous, ...
Biology Products: